MIST
Milestone Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.20
−0.72%Margins
Gross margin
94.6%
EBITDA margin
-3124.6%
EBIT margin
-3353.0%
Net margin
-3585.6%
FCF margin
-2612.7%
-461.1%
Return on equity
-46.3%
Return on assets
-49.1%
Return on invested capital
0.01x
Asset turnover
-$61.2M
Cash from operations
$1.37
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026